Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992572 | SCV001144971 | likely benign | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002549799 | SCV003555503 | uncertain significance | Inborn genetic diseases | 2022-08-02 | criteria provided, single submitter | clinical testing | The c.3148G>A (p.E1050K) alteration is located in exon 13 (coding exon 13) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 3148, causing the glutamic acid (E) at amino acid position 1050 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003936253 | SCV004756446 | likely benign | PKD1-related disorder | 2020-02-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |